Mécanismes de Tumorigenèse et Thérapies Ciblées

Recent papers from Mécanismes de Tumorigenèse et Thérapies Ciblées

1. Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018Journal of Clinical Medicine · 2023
2. Study of the economic impact of cryptosporidiosis in calves after implementing good practices to manage the disease on dairy farms in Belgium, France, and the NetherlandsCurrent Research in Parasitology and Vector-Borne Diseases · 2023
3. Comment on “Binding Affinity Determines Substrate Specificity and Enables Discovery of Substrates for N-Myristoyltransferases”ACS Catalysis · 2022
4. Tracking N-terminal protein processing from the Golgi to the chromatophore of a rhizarian amoebaPLANT PHYSIOLOGY · 2022
5. Overall and net survival of patients with sarcoma between 2005 and 2010: Results from the French Network of Cancer Registries (FRANCIM)Cancer · 2022
6. A Continuous Assay Set to Screen and Characterize Novel Protein N-Acetyltransferases Unveils Rice General Control Non-repressible 5-Related N-Acetyltransferase2 ActivityFrontiers in Plant Science · 2022
7. Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based StudyCancers · 2021
8. Collagen Suprafibrillar Confinement Drives the Activity of Acidic Calcium-Binding Polymers on Apatite MineralizationBiomacromolecules · 2021
9. Expanding the phenotype of X‐linked SSR4–CDG: Connective tissue implicationsHuman Mutation · 2020
10. Long term outcome of MPI‐CDG patients on D‐mannose therapyJournal of Inherited Metabolic Disease · 2020
11. Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007–2014)BMC Cancer · 2020
12. Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM)SHILAP Revista de lepidopterología · 2020
13. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trialContemporary Clinical Trials Communications · 2020
14. Bone Metastasis: Current State of PlayTranslational Oncology · 2019
15. Spatial heterogeneity of KRAS mutations in colorectal cancers in northern FranceCancer Management and Research · 2019
16. Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)United European Gastroenterology Journal · 2019
17. Subterranean Clover Stunt Virus Revisited: Detection of Two Missing Genome ComponentsViruses · 2019
18. Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: An analysis of the French Network of Cancer Registries (FRANCIM) dataInternational Journal of Cancer · 2018
19. Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instabilityOncogenesis · 2018
20. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesisBreast Cancer Research · 2018